Humana Inc. (HUM) To Go Ex-Dividend on June 28th

Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, April 18th, RTT News reports. Shareholders of record on Friday, June 28th will be given a dividend of 0.885 per share by the insurance provider on Friday, July 26th. This represents a $3.54 annualized dividend and a yield of 1.08%. The ex-dividend date of this dividend is Friday, June 28th.

Humana has raised its dividend by an average of 12.3% per year over the last three years and has raised its dividend annually for the last 7 consecutive years. Humana has a payout ratio of 15.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Humana to earn $22.86 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 15.5%.

Humana Stock Performance

NYSE HUM opened at $328.33 on Friday. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm’s fifty day moving average price is $330.40 and its two-hundred day moving average price is $400.99. Humana has a 1 year low of $299.23 and a 1 year high of $541.21. The firm has a market capitalization of $39.61 billion, a P/E ratio of 16.57, a price-to-earnings-growth ratio of 1.90 and a beta of 0.45.

Humana (NYSE:HUM) last posted its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The firm had revenue of $26.46 billion for the quarter, compared to the consensus estimate of $25.47 billion. During the same period last year, the company posted $1.62 earnings per share. The business’s revenue was up 17.9% compared to the same quarter last year. As a group, research analysts anticipate that Humana will post 16.06 EPS for the current year.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Wells Fargo & Company dropped their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Deutsche Bank Aktiengesellschaft lowered shares of Humana from a “buy” rating to a “hold” rating and dropped their price objective for the company from $595.00 to $360.00 in a research report on Thursday, January 25th. Truist Financial reissued a “hold” rating and issued a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Finally, StockNews.com lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $465.42.

Insiders Place Their Bets

In other news, Director Jorge S. Mesquita acquired 545 shares of Humana stock in a transaction on Tuesday, February 20th. The shares were purchased at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.32% of the company’s stock.

Institutional Investors Weigh In On Humana

A number of large investors have recently bought and sold shares of HUM. Cibc World Market Inc. grew its stake in Humana by 4.0% during the first quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock worth $2,484,000 after buying an additional 217 shares in the last quarter. Blair William & Co. IL grew its stake in Humana by 0.6% during the first quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock worth $2,463,000 after buying an additional 32 shares in the last quarter. Cetera Investment Advisers grew its stake in Humana by 0.5% during the first quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock worth $2,135,000 after buying an additional 26 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Humana by 19.0% in the 1st quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock valued at $268,000 after purchasing an additional 98 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. boosted its stake in shares of Humana by 25.0% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after purchasing an additional 5,964 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.